We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
TYRUKO natalizumab 300 mg/15 mL concentrate for infusion vial (425612)
ARTG ID 425612
ARTG Name
TYRUKO natalizumab 300 mg/15 mL concentrate for infusion vial
Product name
TYRUKO natalizumab 300 mg/15 mL concentrate for infusion vial
ARTG Date
Registration Type
Medicine
Therapeutic good type
Medicines
Sponsor
Ingredients
Natalizumab
Licence category
RE
Licence status
A
Summary